NFS-11. PHASE II STUDY OF AXITINIB IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2-RELATED SCHWANNOMATOSIS AND PROGRESSIVE VESTIBULAR SCHWANNOMAS
Publication/Presentation Date
6-2024
Volume
26
Issue
4
Published In/Presented At
Garcia, M. R., Hagiwara, M., Yaffe, A., Mitchell, C., Akshintala, S., Nicolaides, T., Phadnis, S. S., Yohay, K., Feng, Y., Goldberg, J. D., Allen, J. C., & Karajannis, M. A. (2024). NFS-11. PHASE II STUDY OF AXITINIB IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2-RELATED SCHWANNOMATOSIS AND PROGRESSIVE VESTIBULAR SCHWANNOMAS. Neuro-Oncology, 26(Suppl 4), 0. https://doi.org/10.1093/neuonc/noae064.569
Disciplines
Medicine and Health Sciences | Pediatrics
Department(s)
Department of Pediatrics
Document Type
Article
COinS